Are you a healthcare professional?
Dr. Steven Marso, MD
Cardiology*•Male•Age 56
Cardiology*
Dr. Steven Marso, MD is a cardiology specialist in Overland Park, KS. He is affiliated with medical facilities Overland Park Regional Medical Center and Research Medical Center. He is accepting new patients and telehealth appointments.
Midwest Heart and Vascular Specialists - Overland Park
5100 W 110th St Fl 2 Overland Park, KS 66211Accepting new patients
Compare with other Cardiology Specialists
Compare Dr. Marso with our nearby Cardiology Specialists at Menorah Medical Center.
Make an appointment at Menorah Medical Center today at (913) 213-3897.
Filter by
Provider Ratings
These providers are on the medical staff of Menorah Medical Center.
Dr. Marso is a Healthgrades Choice provider in Cardiology
The Healthgrades Choice designation helps you understand the most important factors to consider when choosing a healthcare professional. This designation is earned based on four set standards.
Read our methodology
- Above average experience
- Good hospital quality
- Good patient ratings
- No healthcare sanctions
Experience and Background Checks
Search for experience in a specific area
Background Check
Healthgrades does not collect malpractice claims information for
Background check information is undergoing a refresh. Please check back later.
*The information displayed here is sourced from independent information providers, such as state board websites, as of November 2023, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Dr. Marso's Reviews
Likelihood to recommend Dr. Marso
5.0
12 ratings, 9 with a written review
| 5 Star | 100% | 100% |
| 4 Star | 0% | 0% |
| 3 Star | 0% | 0% |
| 2 Star | 0% | 0% |
| 1 Star | 0% | 0% |
Leave a review
How was your experience with Dr. Marso?Overall Patient Satisfaction
12responses
Likelihood of recommending Dr. Marso to family and friends is 5 out of 5
About Me
Biography
This physician is accepting telehealth visits. Steven P. Marso, MD, is chief medical officer for HCA Midwest Health cardiovascular services. With more...Read more
Specialties*
- Cardiology
- Interventional Cardiology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
University of Virginia Medical Center
Residency Hospital
University of Kansas School of Medicine
Medical School
Mid America Heart Institute|Cleveland Clinic Foundation
Fellowship Hospital, 2003
- Coronary Revascularization Strategies in Patients With Diabetes and Multivessel Coronary Artery Disease: Has the Final Chapter Been Written?
- Prognostic Impact of Periprocedural Bleeding and Myocardial Infarction after Percutaneous Coronary Intervention in Unselected Patients: Results from the EVENT Registry
- The Pathogenesis of Type 2 Diabetes and Cardiovascular Disease
- Improving the Pharmacological Regimen for People with Diabetes Mellitus
- The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis
- Receptor for AGE (RAGE) Mediates Neointimal Formation in Response to Arterial Injury
- Myonecrosis following Isolated Coronary Artery Bypass Grafting is Common and Associated with an Increased Risk of Long-term Mortality
- Incidence, Correlates and Outcomes of Acute, Hospitalacquired Anemia in Patients with Acute Myocardial Infarction.
- Vulnerable plaque intervention: State of the Art
- Diabetes Mellitus is Associated with a Shift in the Temporal Risk Profile In-Hospital Death after Percutaneous Coronary Intervention: An Analysis of 25,223 Patients Over 20 Years
- Comparison of Costs Between Transradial and Transfemoral Percutaneous Coronary Intervention: A Cohort Analysis from the Nationwide Premier Perspective Hospital Database
- Insulin Resistance and Novel Markers of Cardiovascular Disease in Type 2 Diabetes
- Tissue characterisation of atherosclerotic plaque in the left main: an in vivo intravascular ultrasound radiofrequency data analysis
- Diabetes mellitus: Biological Determinants of Atherosclerosis and Restenosis
- Limitations to the use of virtual histologyintravascular ultrasound to detect vulnerable plaque
- Utilization of Distal Embolic Protection in Saphenous Vein Graft Interventions (An Analysis of 19,546 Patients in the American College of Cardiology – National Cardiovascular Data Registry)
- Central Role of RAGE-Dependent Neointimal Expansion in Arterial Restenosis
- Peripheral Arterial Disease in Patients with Diabetes
- Coronary plaque dimensions and composition by intravascular ultrasound radio frequency lesion segment analysis in stable and unstable angina patients
- Excimer laser atherectomy to overcome intraprocedural obstacles in chronic total occlusion percutaneous intervention: Case examples
- An Invasive Strategy is Associated with Decreased Mortality in Patients with Unstable Angina and NonST-Elevation Myocardial Infarction: GUSTO IIb Tria
- Costs of Transradial Percutaneous Coronary Intervention
- Switching patients from clopidogrel to prasugrel in acute coronary syndrome: impact of the clopidogrel loading dose on platelet reactivity
- Chest Pain – A Strong Predictor of Adverse Cardiac Events Following Percutaneous Intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial
- Steatosis and Diastolic Dysfunction: The Skinny on Myocardial Fat
- Revascularization trumps medicine for patients with type 2 diabetes mellitus and chronic angina (or does it?)
- Prognostic Implications of Creatine Kinase-MB Elevation after Percutaneous Coronary Intervention
- Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes
- Optimizing Percutaneous Coronary Revascularization in Diabetic Women: Analysis from the EPISTENT Trial
- Design of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
- Procedural Failure of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from a Multicenter US Registry
- Mode of Death After Contemporary Percutaneous Coronary Intervention: A Report from the Evaluation of Drug Eluting Stents and Ischemic Events
- Diabetes and Percutaneous Coronary Revascularization in the DrugEluting
- Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromes
- Effectiveness of Percutaneous Coronary Interventions to Prevent Recurrent Coronary Events in Patients on Chronic Hemodialysis
- An Intravascular Ultrasound Appraisal of Atherosclerotic Plaque distribution in Diseased Coronary Arteries
- Improvement in Survival Following Successful Percutaneous Coronary Intervention of Coronary Chronic Total Occlusions: Variability by Target Vessel
- Tissue Characterization of Atherosclerotic Plaque in the Left Main: An Intravascular Ultrasound Radiofrequency Data Analysis in Humans
- Percutaneous Intervention of Circumflex Chronic Total Occlusions Is Associated With Worse Procedural Outcomes: Insights From a Multicentre US Registry
- The frequency of vascular complications associated with the use of vascular closure devices varies by indication for cardiac catheterization
- Diabetes, Obesity and Metabolism - Manuscript
- Intravascular Ultrasound Measures of Coronary Atherosclerosis and Estimates of Future Cardiovascular Risk Using the Framingham Risk Score: An Analysis from a Global IVUS Registry
- The Importance of Proteinuria as a Determinant of Mortality Following Percutaneous Coronary Revascularization in Diabetics
- Metabolic Syndrome-Mediated Inflammation following Elective Percutaneous Coronary Intervention
- Multivessel Percutaneous Coronary Intervention In Patients with Multivessel Disease and Acute Myocardial Infarction
- Outcomes of 1090 Consecutive Elective, Non-selected, Percutaneous Coronary Interventions at a Community Hospital without Onsite Cardiac Surgery
- Relationship between Baseline Inflammatory Markers, Antiplatelet Therapy and Adverse Cardiac Events Following Percutaneous Coronary Intervention: An Analysis from the CREDO Trial
- Procedural Outcomes and Long-Term Survival Among Patients Undergoing Percutaneous Coronary Intervention of a Chronic Total Occlusion in Native Coronary Arteries: A 20-Year Experience
- The Paradoxical Benefit of Sulfonylurea Agents in Diabetics Undergoing Coronary Revascularization
- The Impact of Bivalirudin and Vascular Closure Device Use on Percutaneous Coronary Intervention-Related Bleeding
- Quantifying Improvement in Symptoms, Functioning and Quality of Life Following Peripheral Endovascular Revascularization
- Preprocedural estimate of individualized bleeding risk impact physicians’ utilization of bivalirudin during percutaneous coronary intervention
- Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes. A Meta-Analysis of Randomized Clinical Trials
- Cost-Effectiveness of Targeting Patients Undergoing PCI for Therapy with Bivalirudin vs. Heparin Monotherapy According to Predicted Risk of Bleeding
- Comparative Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Elderly Patients Undergoing Revascularization of Chronic Total Coronary Occlusions
- Diabetes Mellitus and Vascular Risk: Continuing the Quest for the Elusive Keystone
- Abciximab Reduces Mortality in Diabetics Following Percutaneous Coronary Intervention
- Proteinuria is a Key Determinant of Death in Patients with Diabetes After Isolated Coronary Bypass Grafting
- Percutaneous coronary intervention use in the United States: defining measures of appropriateness
- Dies clinical presentation affect outcome among patients with acute coronary syndromes undergoing percutaneous coronary intervention? Insights from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study
- Diabetes Duration is Associated with Increased Thin Cap Fibroatheroma
- Comparison of bivalirudin and radial access across a spectrum of preprocedural risk of bleeding in percutaneous coronary intrvention: analysis from the National Cardiovascular Data Registry
- Stratification of risk in thin cap fibroatheromas using peak plaque stress estimates from idealized finite element models
- Comparison of Bivalirudin Versus Heparin(s) During Percutaneous Coronary Interventions in Patients Receiving Prasugrel: A PropensityMatched Study
- Transparency of Appropriateness Criteria
- Improving In-Hospital Mortality in the Setting of an Increasing Risk Profile among Patients Undergoing Catheter-Based Reperfusion for an Acute Myocardial Infarction without Cardiogenic Shock
- Comparison of Bleeding Complications Using Arterial Closure Device versus Manual Compression by Propensity Matching in Patients Undergoing Percutaneous Coronary Intervention
- The Prevalence and Outcomes of Transradial Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Analysis from the NCDR®
- Percutaneous transluminal angioplasty: association between depressive symptoms and diminished health status benefits
- Neointimal Hyperplasia Following Arterial Injury is Increased in a Rat Model of Non-Insulin-Dependent Diabetes Mellitus
- Optimizing the Diabetic Formulary: Beyond Aspirin and Insulin
- Low Adiponectin Levels are Associated with Atherogenic Dyslipidemia and Lipid-Rich Plaque in Non-Diabetic Coronary Arteries.
- What is the Optimal Threshold for Defining a Periprocedural Myocardial Infarction? Prognostic Implications of Creatine Kinase-MB Elevation after Percutaneous Coronary Intervention
- Revascularizing Chronic Total Occlusions: What About the Coronary Collaterals and Myocardial Viability Story?
- Rapid Adoption of Drug Eluting Stents: Clinical Practices and Outcomes from the Early DES Era
- Does Proteinuria Predict Mortality After Percutaneous Revascularization in Diabetics?
- Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaque
- Evaluating the Benefits of GP IIb/IIIa Inhibitors in Heart Failure at Baseline in Acute Coronary Syndromes
- Suspected Acute Coronary Syndrome Patients With Diabetes and Normal Troponin-I Levels Are at Risk for Early and Late Death: Identification of a new high-risk acute coronary syndrome population
- Management of hyperglycemia with the administration of intravenous exenatide to patients in the cardiac intensive care unit
- Comparison of Myocardial Reperfusion in Patients Undergoing Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction With-vs-Without Diabetes Mellitus from the EMERALD Tria
- LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations.
- Acute coronary syndrome in the patient with diabetes: is the management different?
- Comparison of procedural complications with versus without interventional cardiology fellows-in-training during contemporary percutaneous coronary intervention
- Outcomes of Patients with Acute Coronary Syndromes and Prior Coronary Artery Bypass Grafting: Results from the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial
- Success rates of percutaneous coronary intervention of chronic total occlusions and long-term survival in patients with diabetes mellitus
- Association between Bleeding Events and IN-hospital Mortality following Percutaneous Coronary Intervention
- Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study
- Intracoronary Stenting: an Overview for the Clinician
- Relation of Hemoglobin A1C to Left Ventricular Relaxation in Patients with Type 1 Diabetes Mellitus without Overt Heart Disease: A Tissue Doppler Echocardiographic Study
- Incomplete Stent Apposition: Should we Appose or Oppose?
- Procedural Outcomes and Long-Term Survival Among Patients Undergoing Percutaneous Coronary Intervention of a Chronic Total Occlusion inactive Coronary Arteries: A 20-Year Experience
- Diabetes and Percutaneous Coronary Intervention in the Setting of an Acute Coronary Syndrome
- Suitability of Saphenous Vein Graft Lesions for the Use of Distal Embolic Protection
- Diabetes Mellitus is Associated with Plaque Classified as Thin Cap Fibroatheroma: An Intravascular Ultrasound Study
- Optimizing the Percutaneous Interventional Outcomes for Patients with Diabetes Mellitus: Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) Diabetic Substudy
- Predicting restenosis in drug eluting stents placed in real-world clinical practice: Derivation and validation of a risk model from the EVENT registry
- The editor's roundtable: intravascular ultrasonic imaging of the coronary arteries
- Relation between Angio graphic Lesion Severity, Vulnerable Plaque Morphology and Future Adverse Cardiac Events in the Coronary Tree Study
- Plaque burden with composition? That is the next question
- Risk of Restenosis and Health Status Outcomes for Patients Undergoing PCI Vs. CABG Surgery
- Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus
- Drug Eluting Stents and the Use of Percutaneous Coronary Intervention Among Patients with Class I Indications for Coronary Artery Bypass Surgery Undergoing Index Revascularization: Analysis from the National Cardiovascular Data Registry
- Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2–3 liraglutide clinical development studies
- Enhanced Efficacy of Eptifibatide Administration in Patients with Acute Coronary Syndrome Requiring In-Hospital Coronary Artery Bypass Grafting
- Long-Term Survival and Procedural Success in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention of a Chronic Total Occlusion
- Association between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention
- Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G-->C polymorphism and complex plaque morphology
- Atherosclerotic Plaque Composition and Clinical Outcomes in patients with Acute Coronary Syndromes and Metabolic Syndrome or Diabetes: Analysis from the PROSPECT study
- Catheter-Based Reperfusion Of Unprotected Left Main Stenosis During an Acute Myocardial Infarction (the ULTIMA Experience) Unprotected Left Main Trunk Intervention Multi-Center Assessment
- Do Systemic Risk Factors Impact Invasive Findings from Virtual Histology? Insights from the International Virtual Histology Registry
- Amplified Benefit of Clopidogrel versus Aspirin in Patients with a History of Diabetes Mellitus
- Carotid Artery Stenting in the Setting of a Contralateral Carotid Artery Occlusion: Results from the Carotid Artery Revascularization and Endarterectomy (CARE) Registry
- Prospective Natural History Study of Coronary Atherosclerosis using Multimodality Intravascular Imaging
- Temporal Trends in and Factors Associated with Bleeding Complications among patients Undergoing Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data CathPCI Registry
- Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk
- LEADER 3-Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Tria
- .Relationship between paplography and virtual histology in patients with acute coronary syndromes
- Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease
- A Comparison of the Recovery of Health Status after Percutaneous Coronary Intervention and Coronary Artery Bypass
- Immediate Coronary Artery Bypass Surgery After Platelet Inhibition with Eptifibatide: Results from PURSUIT
- Fractional Flow Reserve and Intravascular Ultrasound RelationShip Study: The FIRST Study
- Bleeding in Patients Undergoing Percutaneous Coronary Intervention: The Development of a Clinical Risk Algorithm from the National Cardiovascular Data Registry
- Blood Transfusion During Acute Myocardial Infarction – Association With Mortality and Variability Across Hospitals
- State of the Art: Chronic Total Occlusion Angioplasty in the United States
- Diabetes and Drug Eluting Stents: What You Get and What You Don't (Editorial Comment)
- Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound
- Compensatory enlargement of the left main coronary artery: insights from the PROSPECT study
- Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention
Common Questions and Answers
Please call the office to learn more. (913) 253-3000
Was this information helpful?
What is the best way to schedule an appointment with Dr. Steven Marso, MD?
New patients may call (913) 213-3897 to make an appointment.
What other Cardiology Specialists practice nearby?
Can I use my insurance at Dr. Steven Marso, MD?
Dr. Steven Marso, MD accepts various insurance plans. You can easily check if your insurance provider is accepted by using the Healthgrades insurance check. We recommend verifying your insurance coverage before scheduling an appointment to ensure a seamless experience.
What is Dr. Steven Marso, MD's office address?
Dr. Marso's office is located at 5100 W 110th St Fl 2, Overland Park, KS 66211. You can find other locations and directions on Healthgrades.
Focus on Cardiomyopathy
Insurance Check
Search for your insurance carrier and choose your plan type
Locations
Midwest Heart and Vascular Specialists - Overland Park
Affiliated Hospitals
Recipient of 7
hospital awards
hospital awards
America's 250 Best Hospitals Award™ (2024, 2023)
Superior clinical outcomes in coronary intervention procedures (angioplasty with stent)
Coronary Intervention Excellence Award™ (2024)
Superior clinical outcomes in coronary intervention procedures (angioplasty with stent)
How patients felt about the care they received at this hospital.
83%
Patients said they were given information about recovering at home
1% lower than the national average
74%
Patients said that nurses always listened to them and explained things well
Recipient of 26
hospital awards
hospital awards
Patient Safety Excellence Award™ (2024, 2023, 2022)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
America's 250 Best Hospitals Award™ (2023, 2022)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
How patients felt about the care they received at this hospital.
84%
Patients said they were given information about recovering at home
72%
Patients said that doctors always listened to them and explained things well
3% lower than the national average
Learn more about how Healthgrades measures Hospital Quality.
Compare with other Cardiology Specialists
Compare Dr. Marso with our nearby Cardiology Specialists at Menorah Medical Center.
Make an appointment at Menorah Medical Center today at (913) 213-3897.
Filter by
Provider Ratings
These providers are on the medical staff of Menorah Medical Center.
Your trust is our top concern.
We strive to keep the reviews trustworthy, honest & fair.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.